These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19653933)
1. Urinary excretion of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in nonsmokers and in smokers of cigarettes with different ISO tar yields. Hagedorn HW; Scherer G; Engl J; Riedel K; Cheung F; Errington G; Shepperd J; McEwan M J Anal Toxicol; 2009; 33(6):301-9. PubMed ID: 19653933 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkers. Scherer G; Scherer M; Rögner N; Pluym N Arch Toxicol; 2022 Nov; 96(11):3113-3126. PubMed ID: 35909193 [TBL] [Abstract][Full Text] [Related]
3. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives. Baker RR; Pereira da Silva JR; Smith G Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836 [TBL] [Abstract][Full Text] [Related]
4. Impact of urinary PAHs on psoriasis risk in U.S. adults: Insights from NHANES. Li JH; Yan XN; Fu JY; Hu HY PLoS One; 2024; 19(12):e0314964. PubMed ID: 39636940 [TBL] [Abstract][Full Text] [Related]
5. A consideration of the role of gas/particle partitioning in the deposition of nicotine and other tobacco smoke compounds in the respiratory tract. Pankow JF Chem Res Toxicol; 2001 Nov; 14(11):1465-81. PubMed ID: 11712903 [TBL] [Abstract][Full Text] [Related]
6. Chinese 'low-tar' cigarettes do not deliver lower levels of nicotine and carcinogens. Gan Q; Lu W; Xu J; Li X; Goniewicz M; Benowitz NL; Glantz SA Tob Control; 2010 Oct; 19(5):374-9. PubMed ID: 20507920 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
8. Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis. Glenton C; Paulsen E; Agarwal S; Gopinathan U; Johansen M; Kyaddondo D; Munabi-Babigumira S; Nabukenya J; Nakityo I; Namaganda R; Namitala J; Neumark T; Nsangi A; Pakenham-Walsh NM; Rashidian A; Royston G; Sewankambo N; Tamrat T; Lewin S Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015705. PubMed ID: 39189465 [TBL] [Abstract][Full Text] [Related]
9. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
10. DNA solution(R) in cigarette filters reduces polycyclic aromatic hydrocarbon (PAH) levels in mainstream tobacco smoke. Lodovici M; Akpan V; Caldini S; Akanju B; Dolara P Food Chem Toxicol; 2007 Sep; 45(9):1752-6. PubMed ID: 17459554 [TBL] [Abstract][Full Text] [Related]
11. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers. Carmella SG; Ming X; Olvera N; Brookmeyer C; Yoder A; Hecht SS Chem Res Toxicol; 2013 Aug; 26(8):1209-17. PubMed ID: 23837805 [TBL] [Abstract][Full Text] [Related]
12. [Application of ion chromatographic fingerprint analysis for quality evaluation of tobacco flavors]. Xu GY; He XY; Zhang LN; Liu CS; Gao Y; Huang ZP; Liu HJ; Wu ZM; Zhang RC; Shi H Se Pu; 2024 Aug; 42(8):805-811. PubMed ID: 39086250 [TBL] [Abstract][Full Text] [Related]
14. The unbearable lightness of "light" cigarettes: a comparison of smoke yields in six varieties of Canadian "light" cigarettes. Gendreau PL; Vitaro F Can J Public Health; 2005; 96(3):167-72. PubMed ID: 15913077 [TBL] [Abstract][Full Text] [Related]
15. Determination of methyl-, 2-hydroxyethyl- and 2-cyanoethylmercapturic acids as biomarkers of exposure to alkylating agents in cigarette smoke. Scherer G; Urban M; Hagedorn HW; Serafin R; Feng S; Kapur S; Muhammad R; Jin Y; Sarkar M; Roethig HJ J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2520-8. PubMed ID: 20227354 [TBL] [Abstract][Full Text] [Related]
16. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884 [TBL] [Abstract][Full Text] [Related]
17. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
18. Correlation between cervical carcinogenesis and tobacco use by sexual partners. Siokos AG; Siokou-Siova O; Tzafetas I Hell J Nucl Med; 2019; 22 Suppl 2():184-190. PubMed ID: 31802062 [TBL] [Abstract][Full Text] [Related]
19. A review of in vitro cigarette smoke exposure systems. Thorne D; Adamson J Exp Toxicol Pathol; 2013 Nov; 65(7-8):1183-93. PubMed ID: 23850067 [TBL] [Abstract][Full Text] [Related]